One diagnosis. Different possibilities.
The important question is not simply “Do I have prostate cancer?” It is “How is this cancer likely to behave, and what should we do about it?”
The prostate lies below the bladder and contributes fluid to semen. Some prostate cancers remain slow-growing; others need active treatment. Early disease may cause no symptoms. A high PSA alone does not confirm cancer. [1]
A partner or family member can take notes, help you remember the discussion and support your decisions. Ask for explanations in the language you find most comfortable.
Four pieces of the picture.
A blood marker. Your clinician considers its level, previous readings and prostate size.
MRI identifies suspicious areas. Biopsy establishes the tissue diagnosis. A PI-RADS score is an imaging assessment, not a cancer stage.
Describes how the cancer looks under the microscope. It does not, by itself, tell you whether cancer has spread.
Describes the extent of cancer: confined to the prostate, extending nearby or spread to distant sites.
| Grade Group | Gleason score |
|---|---|
| 1 | 3 + 3 = 6 |
| 2 | 3 + 4 = 7 |
| 3 | 4 + 3 = 7 |
| 4 | 8 |
| 5 | 9–10 |
Gleason 3 + 4 and 4 + 3 are different: the first number represents the predominant pattern. Overall risk combines grade, PSA, clinical stage and other findings. [1]
Do I need more scans or another biopsy?
That depends on the quality and completeness of your existing assessment. Staging scans, including PSMA PET/CT in appropriate risk groups, are not required for everyone. MRI-targeted and systematic biopsy findings help establish where cancer is present; micro-ultrasound can assist biopsy targeting in experienced hands. Bring the actual images as well as reports. [2]
Compare the options that fit you.
Ask your team which choices suit your cancer, general health, life expectancy and priorities. A discussion involving urology, radiation oncology, radiology and pathology can help when several approaches are reasonable.
Active surveillance
Often preferred for suitable low-risk disease. Scheduled PSA tests, clinical review, MRI and repeat biopsy monitor for change, with treatment if needed. Watchful waiting is different: it focuses on symptom control when curative treatment is unlikely to offer benefit. [3]
Radical prostatectomy
Surgery removes the prostate and seminal vesicles, sometimes with pelvic lymph nodes. Robotic surgery is one surgical approach. Discuss urinary leakage, erections, loss of ejaculation and the possibility of additional treatment. [3] Read about robotic surgery →
Radiotherapy
External-beam radiation or brachytherapy may be appropriate. Hormone treatment is added for some risk groups. Discuss urinary, bowel and sexual effects, treatment schedules and longer-term follow-up. [3]
Treatment for advanced disease
Hormone-based treatment is commonly combined with other medicines; selected patients may also receive chemotherapy, radiotherapy or biomarker-directed treatment. The plan depends on disease extent, prior therapy and fitness. [3] Explore advanced cancer care →
Where does focal therapy fit?
Focal treatment aims to destroy a selected cancer-bearing area while preserving untreated prostate tissue.
HIFU uses focused ultrasound energy; IRE uses electrical pulses. Selection requires careful MRI and biopsy review, including assessment of cancer elsewhere in the gland.
Urinary and sexual complications remain possible. PSA, imaging and follow-up biopsy are necessary; further focal treatment, surgery or radiation may be needed.
Long-term comparative evidence is less mature than for established whole-gland treatments. EAU guidance places focal HIFU or cryotherapy within a prospective registry; other ablative approaches should be offered in well-designed prospective trials. Low-risk cancer often suits surveillance rather than ablation. [4]
Understand HIFU and focal therapy →Your priorities belong in the discussion.
Tell your team what matters most: cancer control, urinary function, sexual health, work, caregiving or travel. Ask what recovery may look like for you and what support is available.
- Urinary health: discuss baseline symptoms and rehabilitation.
- Sexual health & fertility: raise concerns before treatment, including future parenthood.
- Emotional wellbeing: ask about counselling if worry is affecting daily life.
- Follow-up: leave with dates, planned tests and a contact for concerns.
Make the practical details part of your plan.
Arrange PSA results by date. Ask your imaging centre for the original MRI images on a disc, USB drive or secure download, and your pathology laboratory how to obtain biopsy slides or blocks if a review is requested.
Ask for an itemised estimate covering investigations, hospital care, medicines and follow-up. Clarify what is included in a treatment package and what may cost extra.
Before admission, ask the hospital insurance desk and your insurer or TPA about authorisation, exclusions, co-payments and documents needed for your proposed treatment. Obtain confirmation rather than assuming a procedure is covered.
If travelling to Noida, ask how long you should stay, whether a caregiver is needed and which follow-up visits or tests can be coordinated with your local doctor. Agree who will review those results.
Include relatives if you wish, while keeping your own preferences central. Ask the team to explain unfamiliar medical terms in your preferred language and write down the next steps.
Bring these. Ask these.
Tick off what you have gathered, then print this checklist or save it as a PDF using your device’s print options. Your selections stay only on this open page.
My documents
My questions
- What are my Grade Group, stage and overall risk?
- Do I need more tests before choosing treatment?
- Is surveillance appropriate for me?
- Which options offer a reasonable balance of cancer control and side effects?
- If considering focal therapy, what are the uncertainties and follow-up requirements?
- What happens if the first treatment does not control the cancer?
- How soon should I decide, and can I seek a second opinion?
- What are the expected costs, insurance requirements and recovery needs?
A few answers to start with.
Does every diagnosis need immediate surgery?
No. Some cancers are suitable for monitoring; others need timely treatment. Ask your clinician to explain your individual risk and decision timeframe.
Does a normal MRI rule out cancer?
No. MRI can miss clinically significant disease. Your PSA, examination, family history and other risk factors still matter when deciding whether a biopsy is needed. [2]
Should I ask about genetic testing?
Tell your team about prostate, breast, ovarian and pancreatic cancers in the family, especially diagnoses at a young age. Whether inherited or tumour testing is useful depends on your history and disease features. Learn about genetic testing →
Can I get a second opinion?
Yes. Bring the original biopsy material if requested, MRI images, reports and treatment records so the reviewing specialist can assess the same evidence.
YOUR NEXT STEP
Turn your reports into a plan.
Discuss your diagnosis with Dr Sachin Arakere Nataraj.
Max Super Speciality Hospital, Sector 128, Noida.
Sources & further reading
General patient education; your treating team will advise on your individual situation. This guide does not provide a diagnosis or predict an individual outcome.
- National Cancer Institute: prostate cancer treatment — patient information
- EAU Guidelines: diagnostic evaluation
- National Cancer Institute: prostate cancer treatment — clinical overview
- EAU Guidelines: treatment, including focal therapy
Sources checked 20 October 2026.